Sort
59,101 grants matching “hypertension”
Central noradrenergic mechanisms of cerebrovascular pathology in Alzheimer's disease
$467,975Scott Edward Counts · Michigan State University · R01 · FY2022 · AG
Efficacy of Web-based Feedback to Improve Blood Pressure Control
$467,871Christopher N. Sciamanna · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2008 · HL
CELLULAR MECHANISMS IN THE INDUCTION OF AROMATASE
$467,863Carole R. Mendelson · Ut Southwestern Medical Center · R01 · FY2011 · DK
Endothelin and Angiotensin Receptor Signaling in Pulmonary Hypertension
$467,822Peter Rudolph Polgar · Boston University Medical Campus · R01 · FY2013 · HL
Reducing depressive symptoms among rural African Americans: REJOICE.
$467,820Tiffany Francine Haynes · Univ Of Arkansas For Med Scis · U01 · FY2016 · MD
Project 4
$467,688Veronique Vanderhorst · Beth Israel Deaconess Medical Center · P01 · FY2020 · HL
Methods in Nephrologic and Urologic Research
$467,685Yale University · T32 · FY2003 · DK
Mechanisms for Cardiovascular Control Early in Diabetes
$467,653Michael W Brands · Augusta University · R01 · FY2014 · HL
B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization
$467,649Rui-Ping Xiao · Aging · Z01 · FY2007 · AG
Mechanosensitive determinants of podocyte physiology
$467,619Evren U. Azeloglu · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DK
Prenatal Events-Postnatal Consequences
$467,573James C. Rose · Wake Forest University Health Sciences · P01 · FY2016 · HD
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
$467,573James C. Rose · Wake Forest University Health Sciences · P01 · FY2016 · HD
Molecular screen for isopeptidase inhibitors to treat pulmonary disease
$467,549David E Sterner · Progenra, Inc. · R44 · FY2011 · HL
Multifactor Risk Reduction for Optimal Management in Peripheral Arterial Disease
$467,523Roberta K Oka · University Of California, San Francisco · R01 · FY2009 · NR
Renal acid ceramidase-S1P pathway in salt-sensitive hypertension
$467,473Ningjun Li · Virginia Commonwealth University · R01 · FY2024 · DK
Renal acid ceramidase-S1P pathway in salt-sensitive hypertension
$467,473Ningjun Li · Virginia Commonwealth University · R01 · FY2025 · DK
Developmental immune programming and postnatal atherosclerosis
$467,446Wulf Palinski · University Of California, San Diego · R01 · FY2008 · HL
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity
$467,438James Matthew Luther · Vanderbilt University Medical Center · R01 · FY2020 · DK
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity
$467,438James Matthew Luther · Vanderbilt University Medical Center · R01 · FY2021 · DK
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity
$467,438James Matthew Luther · Vanderbilt University Medical Center · R01 · FY2018 · DK
Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity
$467,438James Matthew Luther · Vanderbilt University Medical Center · R01 · FY2019 · DK
VISUAL FUNCTION IN GLAUCOMA AND OCULAR HYPERTENSION
$467,414University Of California San Diego · R01 · FY2001 · EY
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates
$467,319Emily J Rogalski · Northwestern University At Chicago · R01 · FY2016 · AG
Effects of Physical Activity Calorie Expenditure (PACE) Food Labeling
$467,265Anthony J Viera · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Effects of Physical Activity Calorie Expenditure (PACE) Food Labeling
$467,265Anthony J Viera · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA